Leading the exosome revolution with cutting-edge purification technology
The power of nanovesicles—exosomes deliver cellular repair and regeneration factors.
Global VisionPioneers
Pioneering the Future with Innovation and Global Expansion
ExoOne Bio. Co., Ltd. is Taiwan's first exosome-based new drug development company, founded at the end of 2020 by Dr. Lin, Tzou-Yien, former Minister of Health and Welfare (Parent agency of Taiwan FDA). With an exceptional medical background and extensive experience across industry, government, and academia, ExoOne has established a solid foundation for developing a unique exosome purification, identification, and separation technology—surpassing international standards and earning multiple patents.
ExoOne's mission is to utilize high-quality exosome biotech products to treat degenerative diseases and promote healthy aging, positioning itself as the world's leading biotech center in anti-aging & rejuvenation.
Building the world's leading biotech center in anti-aging & rejuvenation
Integrity in Business Innovative Breakthroughs
Lead by founder Dr. Lin Tzou-Yien, ExoOne upholds integrity and responsible business practices, producing high-purity new drugs and developing exosome-based skincare products. ExoOne is committed to maintaining the highest standards in manufacturing and management, aligning with international regulations, and driving continuous innovation. As a biotech industry leader in anti-aging and regenerative medicine, ExoOne aims to bring Taiwan's biotechnology industry onto the global stage.
Integrity in Business
Innovative Breakthroughs
Innovative Breakthroughs
Former Minister of CDC (Taiwan)「Tzou-Yien Lin」
Expanding Applications, Breaking Treatment Limits
Exclusive Exosome Purification Technology, Advancing Human Health
New Drug Development – A New Era of Therapeutic Efficacy
- Exclusive exosome purification, identification, and separation technology
- Dedicated to developing new drugs for degenerative diseases, with patented recognition
- CDE-recognized exosome new drug benchmark project
- Collaboration with GMP-certified cell therapy facilities
Anti-Aging Skincare – Global Market Expansion
- Exclusive technology for developing and manufacturing anti-aging skincare products
- Effectively slows skin aging and activates revitalizing factors
- Expanding into international markets, leading a revolution in biotech applications
Next-GenerationBiotech Revolution
Pioneering New-Generation Biomedical SolutionsRevolutionizing human quality of life
Media Coverage
Industry-Government-Academia Collaboration to Make Taiwan's Next ‘Silicon Shield’
Economic Daily News
ExoOne Signs Strategic Cooperation Agreement on Innovative Medicine with the Development Center for Biotechnology
- 2024-09-24
Commercial Times
Development Center for Biotechnology and ExoOne Sign Strategic Agreement to Advance Medical Technology
- 2024-09-24
CommonWealth Magazine
From Cellular Waste to Anti-Aging and Cancer Prevention—What Are Exosomes? If Taiwan Doesn't Act, Korea Will Win the Race!
- 2024-08-19
NOW Health
ExoOne’s Human-Derived Exosomes Approved by the Ministry of Health and Welfare for Use as a Cosmetic Ingredient
- 2024-04-25
Economic Daily News
Lin Tzou-Yien, the Key Figure Behind the Legalization of Human-Derived Exosomes
- 2024-03-29
World Journal
Former Taiwan Minister of Health and Welfare Starts Business at 73, Targeting the ‘Exosome’ Blue Ocean Market
- 2023-06-26
Economic Daily News
Hidden Champion – ExoOne Seizing Biomedical Market Opportunities, A Hope for Degenerative Diseases
- 2023-06-18
GENE ONLINE
Taiwan Exosome Industry-Academia Alliance Established, Paving a New Path for the Biotech Sector
- 2023-04-06
CollaborationInsights
Global Vision, Taiwan Focus
A leader in anti-aging regenerative medicine, guiding Taiwan's biotech industry onto the global stage
